Navigation Links
AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation
Date:5/14/2012

COLUMBUS, Ohio, May 14, 2012 /PRNewswire-USNewswire/ -- Top leaders representing America's advanced medical technology and diagnostics industry came together today to discuss pressing public policy issues affecting job creation and medical innovation and to call for the repeal of the more than $20 billion medical device tax set to begin in January 2013.

U.S. Reps. Patrick J. Tiberi (R-Ohio) and Jim Renacci (R-Ohio) joined Walter M Rosebrough, president and CEO of Mentor, Ohio-based STERIS, and Mike Lynch, executive vice president of Dublin, Ohio-based Cardinal Health, along with Advanced Medical Technology Association (AdvaMed) President and CEO Stephen J. Ubl and BioOhio CEO Tony Dennis, in the policy discussion.

The group had a simple message: The medical technology industry is not only critical to quality health care, but to the creation of innovative new jobs in Ohio and across the country.

Medical technology companies – in Ohio and across the country – are world leaders in the development of new medical devices, diagnostics and essential equipment for patients worldwide, but that leadership is at risk.

"Our industry can be a partner in job creation and an engine for growth for our national economic recovery but public policies need to support that growth and allow us to compete on the global stage. Repealing the device tax is an important first step," Ubl said.

Medical technology is one of the only American manufacturing sectors that has a net trade surplus, exporting $5.4 billion more than it imports. It also accounts for 40 percent of the global technology market. But the U.S.'s lead has shrunk dramatically in the last decade, and we stand to lose further ground with the new tax.

To preserve and protect those jobs and the life-changing innovations created locally, AdvaMed and its member companies have developed a comprehensive Competitiveness Agenda. The agenda focuses on innovation, regulatory, reimbursement, tax and trade policies to drive the U.S. medical technology industry's future growth and success. A copy of the agenda can be found here: http://advamed.org/MemberPortal/Issues/CompetitivenessAgenda.

In Ohio alone, medical technology manufacturers employ more than 35,300 people, paying an average annual wage of $42,689.

Tony Dennis, President and CEO of BioOhio, said: "This is a significant industry for Ohio, not just for corporate expansions and new companies, but also because it provides a path for the continued revival of our manufacturing sector with more traditional companies diversifying into medical devices."

What concerns companies STERIS and Cardinal Health is that the 2.3 percent device tax will hinder medical innovation and result in the loss of up to 43,000 American jobs – some possibly in Ohio.

"We are at a critical time for the U.S. economy; and tax and regulatory policies from Washington can either help or harm American economic growth, innovation, and global competitiveness," said Rosebrough of STERIS. "Much-needed med-tech jobs growth is at risk in Ohio. We have the opportunity to continue to lead the world in medical technology, but only if we all work together to improve the competitive position of American companies."

Cardinal Health's Lynch echoed Rosebrough's sentiment, "Repeal of the device tax will help real jobs in real places like Dublin, Ohio. Repealing it will enable companies like ours to enable healthcare to be more effective and efficient. And repeal will help ensure our industry can continue to innovate and compete successfully around the globe."

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.


'/>"/>
SOURCE AdvaMed
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Annual AdvaMed MedTech Conference Continues Impressive Growth
2. AdvaMed 2011: The MedTech Conference Closing Day Features Life Changing Innovation, Policymaker Addresses
3. AdvaMed 2011: The MedTech Conference Day-Two Focuses on Policies to Promote Life Changing Innovation Around the World
4. Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C.
5. AdvaMed2011: The MedTech Conference Opens with Dialogues on Finance, Competitiveness, Harmonization, Entrepreneurship, Compliance and Health Reform One Year Later
6. Sanovas CEO Larry Gerrans Featured Speaker at AdvaMed 2011
7. Innovative Companies to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C.
8. AdvaMed 2010 Sets New Attendance Record: More than 1,700 Device and Diagnostics Leaders from Across the Country and Around the World Came to Washington, D.C.
9. AdvaMed 2010 Premier Medical Technology Conference Opens Today in Washington D.C. With Executive Workshops, Company Presentations, Innovation Alley Exhibits and Featured Keynote Speakers: FDA Commissioner Dr. Margaret Hamburg, CMS Administrator Dr.
10. ConvaTec to Present at AdvaMed 2010: The MedTech Conference
11. Medical Technology, Funding & Government Experts Address Business, Investment, Reimbursement, Compliance, Innovation, Regulatory and Legal Issues at AdvaMed 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... VIENNA and TAIPEI, Taiwan , ... 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea ... demonstrated a significantly better safety and tolerability profile of ropeginterferon ... data from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV ... PharmaEssentia intends to present this data to the ...
(Date:12/4/2016)... ORLEANS , Dec. 2, 2016  Former Attorney General ... Jr., Esq. , a partner at the law firm of ... commenced an investigation into Lannett Company, Inc. (NYSE: ... Bloomberg published an article titled "U.S. Charges in Generic-Drug ... "antitrust investigation by the Justice Department, begun about two years ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves ... to buy neoprene knee sleeves for lifting and any sport that requires ... on two main aspects to provide a higher quality knee sleeve performance. Firstly it ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... 2016 , ... Halfway through its partnership with First 5 LA, Western University ... than 15,900 children 5 years old and younger and treatment services to more than ... of five years to Western University of Health Sciences, UCLA and USC, beginning March ...
Breaking Medicine News(10 mins):